![]() |
市場調査レポート
商品コード
1394210
ガラクトオリゴ糖(GOS)の世界市場の評価:形状別、用途別、最終用途別、地域別、機会、予測(2016年~2030年)Galacto-oligosaccharides Market Assessment, By Form, By Application, By End-use, By Region, Opportunities and Forecast, 2016-2030F |
||||||
カスタマイズ可能
|
ガラクトオリゴ糖(GOS)の世界市場の評価:形状別、用途別、最終用途別、地域別、機会、予測(2016年~2030年) |
出版日: 2023年12月08日
発行: Market Xcel - Markets and Data
ページ情報: 英文 203 Pages
納期: 3~5営業日
|
世界のガラクトオリゴ糖(GOS)の市場規模は、2022年の50.94キロトンから2030年までに78.18キロトンに達し、2023年~2030年の予測期間にCAGRで5.5%の成長が見込まれています。市場は、その成長と隆盛に寄与しているいくつかの重要な促進要因の影響を受けています。主な促進要因の1つは、腸内健康の重要性に対する意識の高まりです。消費者は現在、健康な腸内細菌叢が全体的なウェルビーイングにどのような影響を与えるかをより意識するようになり、GOSのようなプレバイオティック成分に対する高い需要につながっています。
機能性食品・飲料の人気の向上も、消費者が基本的な栄養を超えた健康利益を提供する製品を求めるようになり、GOSがこうした機能性アイテムに使用されることが多くなっているためです。さらに、ヒトミルクオリゴ糖(HMO)との類似性による乳児用調製粉乳へのGOSの使用が、乳児栄養セグメントにおける需要を促進しています。
さらに、プロバイオティックとプレバイオティック飲料を含む機能性飲料の開発がGOSの使用を拡大しています。これらの飲料は、消化器系の健康を増進する可能性があるとして人気を集めています。結論として、GOSの健康上の利点に関する進行中の調査と臨床研究からの肯定的な結果が、この成分の評判と需要の拡大に寄与していることから、調査と臨床研究がGOS市場の発展において重要な役割を果たしています。
ガラクトオリゴ糖(GOS)のペット飼料への利用は、ペットの健康と栄養の重要性に対する認識の高まりに後押しされ、注目されつつあります。GOSは、ペットの消化器系の健康増進に主眼を置き、ペットの腸内細菌叢をサポートし、消化を助け、胃腸障害の発生を減少させるなど、ペットにさまざまな利益をもたらします。さらに、GOSはペットの免疫システムを強化し、疾患に対する抵抗力を強化し、ペットのアレルギー反応を緩和する可能性を示しており、一般的なペットのアレルギーを管理するための貴重な成分としての地位を確立しています。
例えば、Nestle Purina PetCare Co. は、米国バージニア州キングウィリアム郡にあるペットケア製品の製造施設を拡張するため、1億8,200万米ドルを投資しました。製造の拡大とペット飼料の旺盛な需要が、ガラクトオリゴ糖(GOS)を世界中で強化します。
ガラクトオリゴ糖(GOS)は、栄養補助食品産業において極めて重要な役割を果たしており、特に腸の健康をサポートするという潜在的な健康効果が広く宣伝されています。消化器系の健康への関心の高まりが、栄養補助食品部門におけるGOSの大きな需要を促進しています。さらに、栄養補助食品産業の躍進は、機能性飲料の開発に伴っています。これには、腸内マイクロバイオーム・バランスの改善を通じて全体的な健康増進を目指すプロバイオティクスやプレバイオティクスの飲料や食品のような一連の製品が含まれます。
例えば、2023年7月にFHIRST Living Sodaが飲料市場に参入し、腸の健康をサポートするプロバイオティクスとプレバイオティクスを独自にブレンドした、先駆的な完全天然の無糖飲料であることを示しました。世界中で機能性食品の発売が増加し、ガラクトオリゴ糖(GOS)の需要が増加しています。
GOSは、過敏性腸症候群(IBS)や炎症性腸疾患(IBD)などの症状を含む胃腸障害に関連する症状を緩和する可能性に注目した研究の対象となってきました。GOSは有益な腸内細菌の増殖を促進し、腸の健康増進と関連症状の軽減に役立つことが期待されています。胃腸障害への対応に加え、下痢の管理にも使用されます。そのため、経口補水液のような下痢を緩和するように設計された特定の医薬品の注目成分であり、特に乳幼児における有効性に焦点が当てられています。
例えば、2023年第1四半期、Johnson & Johnsonは米国での売上が約10%増加し、総額125億2,000万米ドルに達したという印象的な結果を報告しました。医薬品の販売の急増は、GOSの需要増に寄与すると予測されます。
当レポートでは、世界のガラクトオリゴ糖(GOS)市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。
Global galacto-oligosaccharides market size was recorded at 50.94 kilotons in 2022, which is expected to grow to 78.18 kilotons in 2030 with a CAGR of 5.5%, during the forecast period between 2023 and 2030. The galacto-oligosaccharides market is influenced by several key drivers that have contributed to its growth and prominence. One of the primary drivers is the increasing awareness of the importance of gut health. Consumers are now more conscious of how a healthy gut microbiome can impact overall well-being, which has led to a higher demand for prebiotic ingredients, like GOS.
The rising popularity of functional foods and beverages is another significant driver as consumers seek products that offer health benefits beyond basic nutrition, and GOS is often used in these functional items. Additionally, the use of GOS in infant formula due to its similarity to human milk oligosaccharides (HMOs) has propelled demand in the infant nutrition segment.
Moreover, the development of functional beverages, including probiotic and prebiotic drinks, has expanded the use of GOS. These beverages have gained popularity for their potential to enhance digestive health. Conclusively, Research and clinical studies have played a significant role in advancing the GOS market as ongoing research into the health benefits of GOS and positive results from clinical studies have contributed to the growing reputation and demand for this ingredient.
The utilization of Galacto-oligosaccharides (GOS) in pet feed is gaining prominence, driven by the growing recognition of the significance of pet health and nutrition. GOS offers a range of benefits for pets, with a primary focus on enhancing their digestive health, and supports the pet's gut microbiome, aids in digestion, and diminishing the occurrence of gastrointestinal issues. Moreover, GOS has demonstrated its potential in fortifying the immune system of pets, bolstering their resistance to diseases and serve to mitigate allergic reactions in pets, thus establishing itself as a valuable ingredient for the management of common pet allergies.
For instance, Nestle Purina PetCare Co. allocated an investment of USD 182 million to expand its manufacturing facility for pet care products in King William County, Virginia, the United States. Expansion of manufacturing and strong demand for pet feed to strengthen the Galacto-oligosaccharides globally.
Galacto-oligosaccharides play a pivotal role in the dietary supplements industry, where it is widely promoted for its potential health benefits, particularly in supporting gut health. The increasing focus on digestive well-being has driven significant demand for GOS within the dietary supplements sector. Moreover, the surge in the dietary supplements industry has been accompanied by the development of functional beverages. It includes a range of products like probiotic and prebiotic drinks and foods that aim to enhance overall health through improved gut microbiome balance.
For instance, during July 2023, FHIRST Living Soda entered the beverage market, marking the pioneering all-natural, sugar-free drink that uniquely blends probiotics and prebiotics to support gut health. The rise in launches of functional foods across the globe increases the demand for galacto-oligosaccharides.
GOS has been the subject of research focused on its potential to mitigate symptoms associated with gastrointestinal disorders, including conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). GOS fosters the proliferation of beneficial gut bacteria and has shown promise and helps in enhancing gut health and diminishing associated symptoms. In addition to addressing gastrointestinal disorders, it is used for managing diarrhea. Therefore, it is a featured ingredient in specific pharmaceutical products, such as oral rehydration solutions, designed to alleviate diarrhea, with a particular focus on its efficacy in infants and young children.
For instance, during Q1 of 2023, Johnson & Johnson reported impressive results in their sales experiencing a robust upswing of nearly 10 percent in the United States, reaching a total of USD 12.52 billion. The upsurge in sales of pharmaceuticals is expected to contribute to rising demand for GOS.
The galacto-oligosaccharides market experienced significant disruption due to the outbreak of COVID-19. Although the pandemic had a relatively milder impact on the food and beverage industry compared to other sectors, it severely affected the industry's global supply chain, constraining its growth potential. The shift in consumer behavior during this time had a detrimental effect on purchasing patterns, resulting in several challenges, including operational halts, hindrances to business expansion, and suspended activities. However, on the other hand, the lockdown heightened demand for GOS in few applications as the need for pet feed and prebiotic drinks increased during the pandemic.
A huge percentage of the population of people across the globe is lactose intolerant, which is a major restrain to the market. However, the development of plant-based GOS will witness a consumption increase within this population.
The ongoing research of GOS in pharmaceuticals along with growing awareness of gut health will improve the demand for galacto-oligosaccharides market globally.
Key players in the galacto-oligosaccharide market are actively involved in the creation of innovative products, primarily intended to function as dietary supplements. This strategic initiative is coordinated with the increasing worldwide need for nutritional supplements and the industry's adaptability to changing consumer preferences in this regard. It underscores a dedication in addressing the rising market requirements for health-oriented products, emphasizing a pivotal role of galacto-oligosaccharide in modern dietary solutions.
For instance, in August 2022, FrieslandCampina Ingredients created a specialized prebiotic with the aim of spurring innovation in the expanding market for gut health supplements. Featuring an exceptionally high galacto-oligosaccharide content of more than 90%, Biotis GOS-OP High Purity stands as the company's most refined prebiotic ingredient.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.